US 9,272,983 B2Granted

2-amino-3-methyl-hex-5-enoic acid and its use in the production of peptides including bacitracins

AssigneeXellia Pharmaceuticals Aps

InventorsMartin Mansson, Christine Senstad, Jon Efskind, Vidar Bjornstad

Life of this patent

Estimating the term…

Abstract

The present invention concerns 2-amino-3-methyl-hex-5-enoic acid, its use for the production of peptides such as bacitracins and a method for producing it.

Claims8

Dependent claims

The compound 2-amino-3-methyl-hex-5-enoic acid.

Dependencies are inferred from the claim text.

Facts

Application: 13/502,144Filed 30 Sep 2010 · us provisional application
Priority: 28 Oct 2009
Published: US 2012/0202968 A19 Aug 2012
Granted: 1 Mar 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07C 229/08
Having only one amino and one carboxyl group bound to the carbon skeleton: the nitrogen atom of the amino group being further bound to hydrogen atoms
C07C 229/30
Having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton: the carbon skeleton being acyclic and unsaturated
C07K 7/58
The cyclisation not occurring through 2,4-diamino-butanoic acid: bacitracins; Related peptides
C07C
Acyclic or carbocyclic compounds

Family

Application61/255,521Us provisional application · filed 28 Oct 2009
US 2012/0202968 A1Pre-grant publication · published 9 Aug 2012
US 9,272,983 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…